TS03 Inc Trust Units TSTIF

Catalysts

[Freedm40somthng]

As we head into the final 4 months of 2016, and current SP is facing headwinds on low volume and boredom.  Its important for current investors and potential new investors to be reminded of what is in the near term pipeline and hence could happen at any moment (let alone by end of 2016).  This is not yet a company where you just wait for Q results 4 times a year.  In fact, i plan on selling into an offer before the end of 2017, which means RR will only be doing a few more Q CC's.


1.  Update on Olympus device compatibility
2.  Prestigious Hospital placement/Current Customers
3.  Double door machine 
4.  European Launch
5.  Enhanced cycle efficiency on current installed machines
6.  Further FDA claims
7.  80L development
8.  Manufacturing capacity/Capital Planning
9.  US Listing/US Investor base
10.  Global reach (Asia, Australia, etc)
11.  Q3 Results (provide clean look at full Q of production/inventory, ramp in sales)
12.  A TSO3 purchase of a synergistic company
13.  A buyout by Gentinge, JJ, 3M, Olympus, Private Equity

If i have missed anything feel free to add as item #14 and beyond.  These 13 items are the reason to buy at these $3 levels. (or not sell at these levels)  Regulatory challenges, cash flow levels, and partnership issues are behind us, basically de-risking TSO3 to production and sales risk only.